B69.0 Cysticercosis of central nervous system

Name of the Condition

• Cysticercosis of central nervous system

Summary

Cysticercosis of the central nervous system (CNS) is a parasitic infection caused by the larval stage of the pork tapeworm, Taenia solium. The condition occurs when ingested tapeworm eggs develop into cysts (larvae) within the brain or spinal cord, leading to neurocysticercosis. It is a significant cause of neurological disease in endemic regions and can present with a range of symptoms depending on cyst location, number, and viability.

Causes

The infection is caused by the larval form of Taenia solium, which is acquired by ingesting eggs from contaminated food, water, or surfaces. The eggs hatch in the intestine, and larvae penetrate the intestinal wall to migrate to tissues, where they form cysts. Human-to-human transmission occurs via the fecal-oral route, often through poor sanitation or consumption of undercooked pork.

Risk Factors

• Residence in or travel to areas with poor sanitation and high Taenia solium prevalence.
• Consumption of undercooked pork or contaminated food/water.
• Close contact with individuals carrying the adult tapeworm (e.g., household members).
• Immunocompromised states that may alter disease progression.

Symptoms

• Neurological symptoms (e.g., seizures, headaches, focal deficits) if cysts affect the brain.
• Muscle or subcutaneous cysts, which may be palpable or asymptomatic.
• Visual disturbances or cranial nerve palsies if cysts involve the eyes or cranial nerves.
• Increased intracranial pressure, leading to nausea, vomiting, or altered mental status.

Diagnosis

Diagnosis typically involves a combination of clinical evaluation, neuroimaging (e.g., MRI or CT scans), and serological testing. Neuroimaging may reveal characteristic cystic lesions in the brain or spinal cord. Serological tests, such as enzyme-linked immunoelectrotransfer blot (EITB), can detect antibodies to Taenia solium antigens. Lumbar puncture may be performed to assess cerebrospinal fluid for inflammatory changes or antibodies.

Treatment Options

Treatment depends on cyst location, number, and symptoms. Antiparasitic medications (e.g., albendazole or praziquantel) may be used to target viable cysts. Corticosteroids are often administered to reduce inflammation and prevent complications like edema. Anticonvulsants are prescribed for seizure management. In cases of hydrocephalus or mass effect, surgical intervention may be necessary.

Prognosis and Follow-Up

Prognosis varies based on cyst burden, location, and treatment response. Early diagnosis and appropriate therapy improve outcomes. Follow-up typically includes monitoring for symptom recurrence, imaging to assess cyst resolution, and ongoing management of complications (e.g., seizures or hydrocephalus). Long-term follow-up may be required for patients with residual cysts or neurological deficits.

Complications

• Seizures, which may be recurrent or refractory to treatment.
• Hydrocephalus due to cyst obstruction of cerebrospinal fluid flow.
• Neurological deficits (e.g., weakness, sensory loss) from cyst-induced damage.
• Cyst degeneration, leading to inflammation or mass effect.
• Rarely, cyst rupture, which can cause severe inflammation or death.

Lifestyle & Prevention

• Avoid consuming undercooked pork or contaminated food/water.
• Practice good hygiene, including handwashing and proper sanitation.
• Cook pork to safe internal temperatures (at least 145°F/63°C).
• Avoid contact with feces from infected individuals or carriers.
• In endemic areas, consider public health measures to reduce transmission.

When to Seek Professional Help

Seek medical attention if experiencing new or worsening neurological symptoms (e.g., seizures, severe headaches, vision changes) or signs of increased intracranial pressure (e.g., nausea, vomiting, confusion). Prompt evaluation is critical for early diagnosis and treatment to prevent complications.

Tips for Medical Coders

Document the specific location of CNS involvement (e.g., brain, spinal cord) and any associated symptoms or complications. Ensure clinical documentation supports the diagnosis and treatment provided. For coding, use B69.0 for cysticercosis of the central nervous system, and include any relevant modifiers or additional codes for complications (e.g., seizures, hydrocephalus) as appropriate.